Brandywine Realty Trust (BDN) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
26 May, 2026Strategic focus and market positioning
Core portfolio benefits from a flight to quality, with 94% of 2026 speculative revenue projection achieved and 182,000 sq ft of forward lease commencements.
No unsecured bond maturities until November 2027 and minimal borrowings on unsecured credit facility support liquidity.
Accelerated asset recycling program and recapitalization of Austin developments planned for 2026.
Philadelphia and Austin are key markets, with Philadelphia accounting for 81% of NOI and Austin 12%.
Major events in Philadelphia in 2026 expected to generate $1.3B–$2.5B in economic impact and support up to 17,000 jobs.
Portfolio performance and leasing activity
1Q 2026 core portfolio leasing activity reached its highest level since 4Q 2024.
60% of new leasing activity in Philadelphia region driven by flight-to-quality deals.
Net effective rent growth in Philadelphia CBD averaged 5.4% since 2021.
Office occupancy at 88.3%, outperforming peers at 86.2%.
Cash same store NOI growth at 3.3%, higher than peer average of 0.5%.
Major development projects
Uptown ATX is a 66-acre mixed-use, transit-oriented community with 688,000 SF existing buildings and future office, residential, hotel, and retail components.
One Uptown features a 14-story office tower and 341 residential units, with office stabilization expected in Q4 2026 and residential in Q3 2025.
Schuylkill Yards in Philadelphia is a multi-phase, transit-rich development with 3.9M SF of life science, innovation, and office space, plus 1.2M SF residential.
Recent completions include 3025 JFK and 3151 Market, delivering 200,000 SF life science/office, 417,000 SF dedicated life science, and 326 apartments.
Life science incubator B+ labs is 76% leased; graduate lab space at Cira Centre is 93% leased.
Latest events from Brandywine Realty Trust
- All proposals passed unanimously, with no shareholder questions raised.BDN
AGM 20261 Jun 2026 - FFO met guidance, leasing and asset sales strong, but net loss widened on impairments.BDN
Q1 20261 May 2026 - 2026 guidance targets FFO growth, higher occupancy, major asset sales, and debt reduction.BDN
Q4 202513 Apr 2026 - Proxy covers trustee elections, auditor ratification, executive pay, and incentive plan amendment.BDN
Proxy filing7 Apr 2026 - Key votes include trustee elections, auditor ratification, and incentive plan amendment.BDN
Proxy filing7 Apr 2026 - Flexible $1.5B shelf registration for equity and debt, supporting growth and REIT compliance.BDN
Registration Filing10 Mar 2026 - Balance sheet simplification, asset sales, and life science growth drive the 2026 outlook.BDN
Citi’s Miami Global Property CEO Conference 20263 Mar 2026 - Q2 2024 net income surged on a one-time gain, but FFO and occupancy declined.BDN
Q2 20243 Feb 2026 - Q3 2024 net loss on impairments; FFO $0.23/share; liquidity and asset sales targets strong.BDN
Q3 202419 Jan 2026